Gland Pharma Limited Return on Assets (ROA) for the year ending March 31, 2025: 6.22%

Gland Pharma Limited Return on Assets (ROA) is 6.22% for the year ending March 31, 2025, a -14.11% change year over year. Return on assets measures profitability against assets; higher ROA indicates efficient asset use and profitability.
  • Gland Pharma Limited Return on Assets (ROA) for the year ending March 31, 2024 was 7.25%, a -18.57% change year over year.
  • Gland Pharma Limited Return on Assets (ROA) for the year ending March 31, 2023 was 8.90%, a -42.47% change year over year.
  • Gland Pharma Limited Return on Assets (ROA) for the year ending March 31, 2022 was 15.47%, a 0.78% change year over year.
  • Gland Pharma Limited Return on Assets (ROA) for the year ending March 31, 2021 was 15.35%, a -18.86% change year over year.
Key Data
Date Return on Assets (ROA) Revenue Per Share Free Cash Flow Per Share Dividend Per Share